Famotidine
NDC 60219-2090, Famotidine, powder, for suspension, from Amneal Pharmaceuticals NY LLC.
- Product NDC
- 60219-2090
- Status
- Listed
- Labeler
- Amneal Pharmaceuticals NY LLC
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216427
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60219-2090 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FAMOTIDINE40 mg/5mL
Pharmacologic classes
Histamine H2 Receptor Antagonists [MoA]; Histamine-2 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60219-2090-4 | 60219209004 | 50 mL in 1 BOTTLE (60219-2090-4) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/443e8ea6-7d51-4db7-8f0b-7a854d45bf23NADAC price for package 60219209004
GET /v1/drugs/nadac/60219209004
Use it
Look up 60219-2090 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60219-2090 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60219-2090. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.